Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.72 USD | -2.28% | +1.07% | -8.17% |
Financials (USD)
Sales 2024 * | 1.06M | Sales 2025 * | 170K | Capitalization | 128M |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -61M | EV / Sales 2024 * | 12.7 x |
Net cash position 2024 * | 114M | Net cash position 2025 * | 60.6M | EV / Sales 2025 * | 395 x |
P/E ratio 2024 * |
-2.95
x | P/E ratio 2025 * |
-2.41
x | Employees | 37 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.82% |
Latest transcript on Vistagen Therapeutics, Inc.
1 day | -2.28% | ||
1 week | +1.07% | ||
Current month | -10.61% | ||
1 month | +13.19% | ||
3 months | -1.77% | ||
6 months | +58.39% | ||
Current year | -8.17% |
Managers | Title | Age | Since |
---|---|---|---|
Shawn Singh
CEO | Chief Executive Officer | 61 | 99-12-31 |
Cynthia Anderson
DFI | Director of Finance/CFO | 55 | 23-08-20 |
Joshua Prince
COO | Chief Operating Officer | 54 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Saxe
CHM | Chairman | 88 | 00-05-31 |
Jerry Gin
BRD | Director/Board Member | 81 | 16-02-29 |
Shawn Singh
CEO | Chief Executive Officer | 61 | 99-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 18 M€ | +3.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 4.72 | -2.28% | 147,555 |
24-04-23 | 4.83 | +1.05% | 189,955 |
24-04-22 | 4.78 | +0.42% | 138,367 |
24-04-19 | 4.76 | +1.28% | 152,293 |
24-04-18 | 4.7 | +0.64% | 197,530 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.17% | 128M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.86% | 22.2B | |
-16.53% | 21.23B | |
-8.49% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- VTGN Stock